Literature DB >> 9031375

Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment.

S Welsch1, D W Branch.   

Abstract

To be sure, antiphospholipid antibody syndrome is a protean disease with many manifestations, some of which are exacerbated during pregnancy, and some of which even lead to its initial diagnosis during pregnancy. Although the best treatment during pregnancy is uncertain at this point, and some of the treatments are even experimental, there does seem to be a benefit in at least identifying and probably treating those with risk factors. If treatment is not instituted with heparin, aspirin, or other medical management, at least monitoring for the known superimposed disease states, such as intrauterine growth retardation, preeclampsia, and fetal loss, should be judicious, with close antenatal surveillance.

Entities:  

Mesh:

Year:  1997        PMID: 9031375     DOI: 10.1016/s0889-857x(05)70315-x

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  3 in total

Review 1.  Treatment of the antiphospholipid antibody syndrome: progress in the last five years?

Authors:  M Petri
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

2.  Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall.

Authors:  E DiFederico; O Genbacev; S J Fisher
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 3.  Pregnancy in systemic lupus erythematosus.

Authors:  C C Mok; R W Wong
Journal:  Postgrad Med J       Date:  2001-03       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.